Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2356 AL 2370

Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease

Fu Y, Zhao D, Yang L.

J Mol Neurosci. 2014 Dec;54(4):739-47. doi: 10.1007/s12031-014-0356-x. Epub 2014 Jun 25.

Comparison of two analytical platforms for CSF biomarkers of Alzheimer's disease

Monge-Argilés JA, Muñoz-Ruiz C, Sánchez-Payá J, Gasparini Berenguer R, Blanco Cantó ME, Leiva-Santana C.

Biomed Res Int. 2014;2014:765130. doi: 10.1155/2014/765130. Epub 2014 May 29.

[Biomarkers of Alzheimer disease]

Rachel W, Grela A, Zyss T, Zieba A, Piekoszewski W.

Przegl Lek. 2014;71(2):98-101.

Biomarkers for preclinical Alzheimer's disease

Tan CC, Yu JT, Tan L.

J Alzheimers Dis. 2014;42(4):1051-69. doi: 10.3233/JAD-140843.

[Progress of dementia medicine: Special reference to Alzheimer's disease]

Utsumi K.

Hokkaido Igaku Zasshi. 2014 May;89(1):21-3.

Influence of lifestyle modifications on age-related free radical injury to brain

Peskind ER, Li G, Shofer JB, Millard SP, Leverenz JB, Yu CE, Raskind MA, Quinn JF, Galasko DR, Montine TJ.

JAMA Neurol. 2014 Sep;71(9):1150-4. doi: 10.1001/jamaneurol.2014.1428.

Matrix metalloproteinases and their multiple roles in Alzheimer's disease

Wang XX, Tan MS, Yu JT, Tan L.

Biomed Res Int. 2014;2014:908636. doi: 10.1155/2014/908636. Epub 2014 Jun 24.

[Base excision repair in Alzheimer's disease]

Kwiatkowski D, Sliwiński T.

Postepy Hig Med Dosw (Online). 2014 Jul 22;68:976-86. doi: 10.5604/17322693.1114036.

A systematic review of amyloid-β peptides as putative mediators of the association between affective disorders and Alzheimer׳s disease

Abbasowa L, Heegaard NH.

J Affect Disord. 2014 Oct;168:167-83. doi: 10.1016/j.jad.2014.06.050. Epub 2014 Jul 6.

Comparison of dual-biomarker PIB-PET and dual-tracer PET in AD diagnosis

Fu L, Liu L, Zhang J, Xu B, Fan Y, Tian J.

Eur Radiol. 2014 Nov;24(11):2800-9. doi: 10.1007/s00330-014-3311-x. Epub 2014 Aug 6.

Chromosomal DNA damage measured using the cytokinesis-block micronucleus cytome assay is significantly associated with cognitive impairment in South Australians

Lee SL, Thomas P, Hecker J, Faunt J, Fenech M.

Environ Mol Mutagen. 2015 Jan;56(1):32-40. doi: 10.1002/em.21890. Epub 2014 Aug 6.

The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations

Mormino EC.

Neuropsychol Rev. 2014 Sep;24(3):300-12. doi: 10.1007/s11065-014-9267-4. Epub 2014 Aug 10.

Meta-analysis of the association between two neprilysin gene polymorphisms and Alzheimer's disease

Guo X, Tang P, Liu P, Liu Y, Hou C, Li R.

J Neurol Sci. 2014 Nov 15;346(1-2):6-10. doi: 10.1016/j.jns.2014.07.064. Epub 2014 Aug 7.

Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study

Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, Abner EL, Petersen RC, Federoff HJ, Miller BL, Goetzl EJ.

Alzheimers Dement. 2015 Jun;11(6):600-7.e1. doi: 10.1016/j.jalz.2014.06.008. Epub 2014 Aug 15.

Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trials

Jia Q, Deng Y, Qing H.

Biomed Res Int. 2014;2014:837157. doi: 10.1155/2014/837157. Epub 2014 Jul 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias